Loading Events

« All Events

Redeye Orphan Drugs Seminar – April 2021

April 28 @ 11:15 - 11:35

Ascelia Pharma’s Chief Medical Officer, Carl Bjartmar will present at Redeye Orphan Drugs Seminar.
The presentation will be live streamed, to register to the event:


April 28
11:15 - 11:35

About us

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.

Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)

Download our fact sheet: Ascelia Pharma Factsheet Dec 2020